Journal of Oncology / 2019 / Article / Tab 2

Research Article

Portal Vein Embolization with PVA and Coils before Major Hepatectomy: Single-Center Retrospective Analysis in Sixty-Four Patients

Table 2

PVE and main outcome.

Number of patients64
PVE segments, N (%)
 Right53 (82.81)
 Right + IV2 (3.12)
 Right + RHV1 (1.56)
 Left5 (7.81)
 Left + ARS3 (4.69)
PVE ipsi or contralateral, N (%)
 Contra1 (1.56)
 Ipsi63 (98.44)
PVA total vials, mean (SD)7.75 (2.93)
Total coils, mean (SD)9.73 (4.21)
Adverse events, N (%)
 Fever3 (4.69)
 Hemoperitoneum and hemothorax: angiography did not reveal active bleeding1 (1.56)
 Left arterial branch lateration1 (1.56)
 Nausea and vomiting1 (1.56)
 None58 (90.62)
Hospital stay in days, mean (SD)2.59 (1.61)
TFLV, mean (SD)1399.02 (346.92)
TFLV after PVE, mean (SD)1428.62 (379.58)
FLRV, mean (SD)484.31 (241.64)
FLRV after PVE, mean (SD)653.61 (286.66)
Right liver volume before PVE, mean (SD)984.89 (393.31)
Right liver volume after PVE, mean(SD)853.06 (386.42)
Tumor volume before PVE, mean (SD)114.03 (377.4)
Tumor volume after PVE, mean (SD)137.76 (385.8)
Increase in the FLR ratio, mean (SD)11.14 (4.83)
Increase in the FLR percent degree of hypertrophy, mean (SD)40.16 (28.75)

PVE: portal vein embolization; RHV: right hepatic vein; ARS: anterior right sector; TFLV: total functional liver volume; FLRV: future liver remnant volume; FLR: future liver remnant.